Medicare Enrolled

Dr. Rebecca Marsh, M.D.

Infectious Disease · Hillsborough, NJ
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
105 RAIDER BLVD, Hillsborough, NJ 08844
9082810221
In practice since 2007 (19 years)
NPI: 1285773606 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marsh from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marsh? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marsh

Dr. Rebecca Marsh is an infectious disease specialist in Hillsborough, NJ, with 19 years of NPI registration. Based on federal Medicare data, Dr. Marsh performed 2,001 Medicare services across 1,331 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marsh received a total of $1,668 from 23 pharmaceutical and/or device companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in infectious disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marsh is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 33% volume in NJ $1,668 industry payments

Medicare Practice Summary

Medicare Utilization ↗
2,001
Medicare services
Top 33% in NJ for infectious disease
1,331
Unique beneficiaries
$103
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~105 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
807 $97 $156
Initial hospital admission, moderate complexity
Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter.
419 $111 $220
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
402 $66 $104
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
351 $149 $294
Initial nursing facility care, high complexity
An initial visit by a healthcare provider to a patient in a nursing facility involving a high level of medical decision making, lasting at least 45 minutes.
22 $156 $258
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$1,668
Total received (2018-2024)
Avg $238/year across 7 years
Top 32% in NJ for infectious disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
23
Companies
98
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$1,668 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$629
2023
$327
2022
$127
2021
$241
2020
$84
2019
$174
2018
$88

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Merck Sharp & Dohme LLC
$165
ABBVIE INC.
$153
PFIZER INC.
$104
AIMMUNE THERAPEUTICS, INC.
$51
Ferring Pharmaceuticals Inc.
$46
Gilead Sciences, Inc.
$32
Shionogi Inc
$18
Insmed, Inc.
$18
Paratek Pharmaceuticals, Inc.
$18
Janssen Pharmaceuticals, Inc
$13
CashFlow Solutions, LLC
$9
Top 3 companies account for 67.2% of 2024 payments
All-time payments by company (2018-2024) ›
ABBVIE INC.
$346
Merck Sharp & Dohme LLC
$279
PFIZER INC.
$175
AbbVie Inc.
$127
Janssen Pharmaceuticals, Inc
$120
Allergan Inc.
$108
Smith+Nephew, Inc.
$106
AIMMUNE THERAPEUTICS, INC.
$51
Ferring Pharmaceuticals Inc.
$46
ORGANOGENESIS INC.
$40
BioMonde US LLC
$34
Gilead Sciences, Inc.
$32
La Jolla Pharmaceutical Company
$28
Merck Sharp & Dohme Corporation
$27
Osiris Therapeutics Inc.
$22
KCI USA, Inc.
$21
Shionogi Inc
$18
Insmed, Inc.
$18
Paratek Pharmaceuticals, Inc.
$18
Allergan, Inc.
$16
E.R. Squibb & Sons, L.L.C.
$15
Smith & Nephew, Inc.
$12
CashFlow Solutions, LLC
$9
Top 3 companies account for 47.9% of all-time payments
Associated products mentioned in payments ›
AVYCAZ · Arikayce · COLLAGENASE SANTYL · DALVANCE · DIFICID · ELIQUIS · Fetroja · GARDASIL · LYMPHA PRESS OPTIMAL PLUS(US) BT · MAVYRET · NUZYRA · OCTAGAM IMMUNE GLOBULIN (HUMAN) · PIFELTRO · PREVYMIS · Puraply · Puraply Antimicrobial · REBYOTA · SNAP · Santyl · Stravix · TEFLARO · VOWST · XARELTO · XERAVA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an infectious disease specialist in Hillsborough?
Compare infectious diseases in the Hillsborough area by procedure volume, costs, and industry payment transparency.
Browse infectious diseases nearby

Geographic Context

Infectious diseases within 10 mi
114
Per 100K population
32.9
County median income
$135,960
Nearest hospital
HACKENSACK MERIDIAN HEALTH CARRIER CLINIC
3.5 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Marsh is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Marsh experienced with hospital follow-up visit, high complexity?
Based on Medicare claims data, Dr. Marsh performed 807 hospital follow-up visit, high complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marsh receive payments from pharmaceutical companies?
Yes. Dr. Marsh received a total of $1,668 from 23 companies across 98 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marsh's costs compare to other infectious diseases in Hillsborough?
Dr. Marsh's average Medicare payment per service is $103. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marsh) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →